Progetti di ricerca

JA PreventNCD - Prevenzione del cancro e di altre malattie croniche a lungo decorso non trasmissibili: azione sui determinanti della salute (Progetto Nr. 10128023)

JA PreventNCD - Cancer and other NCDs prevention - action on health determinants (Project Nr. 10128023)

Il cancro e le altre malattie non trasmissibili (C&NCD) rappresentano oltre i 2/3 delle malattie in Europa. Lo scopo di questo progetto è sostenere strategie e politiche pianificate per ridurre il carico di queste malattie, i fattori di rischio comuni sia a livello personale che sociale e definire metodi per valutarne l’efficacia in tutta Europa. Il progetto analizzerà le opportunità per implementare politiche intersettoriali basate sull’evidenza per prevenire le malattie croniche e non comunicabili; test pilota per la selezione delle pratiche più promettenti e migliorando quelle più innovative, includendo attività di prevenzione mirati e basati sulla popolazione promuovere una vita sana; monitorare la mortalità e la morbilità delle malattie non trasmissibili, l’esposizione ai fattori di rischio comuni, il costo delle malattie non trasmissibili e per la cura del cancro, l’impatto degli sforzi di promozione della salute e di prevenzione delle malattie sia a livello personale che sociale. Questa azione comune rappresenta uno sforzo ambizioso per fornire una guida strategica e consolidata nel campo della prevenzione delle malattie croniche non trasmissibili. I principali risultati includono un consorzio dell’Unione Europea dedicato alla prevenzione del cancro, eventi annuali di alto livello, interventi e raccomandazioni politiche che contribuiranno a ridurre l’onere delle malattie croniche e delle malattie non trasmissibili e la disuguaglianza in tutta Europa.

Cancer and other Non Comunicable Diseases (C&NCD) make up more than 2/3 of the burden of disease in Europe. The aim of the Joint Action on Cancer and other NCDs prevention - Action on Health Determinants is to support strategies and policies designed to reduce the burden of C&NCDs, their common risk factors both at a personal and societal level, and to define methods to assess their effectiveness across Europe. The project will analyse the opportunities for implementing evidence based inter sectoral policies for preventing C&NCDs; pilot test innovative practices and scale-up best practices, including both population-based and targeted prevention efforts to promote healthy living; monitor C&NCD mortality and morbidity, exposure to the common risk factors, cost of NCD and cancer care, and the impact of health promotion and disease prevention efforts both at a personal and societal level. This Joint Action represents an ambitious effort to provide strategic guidance and consolidated efforts to the field of C&NCD prevention. Key outputs include an EU Consortium on Cancer Prevention, high-level annual events, and intervention tools and policy recommendations that will contribute to reduced C&NCD burden and inequality across Europe.

Ente finanziatore

European Health and Digital Executive Agency (HADEA) under the powers delegated by the European Commission - EU4Health programme

Fonte di finanziamento

Europea

Data inizio

1 gennaio 2024

Data di termine

31 dicembre 2028

Ruolo dell'Istituto

Ente affiliato

Struttura

Epidemiologia oncologica

Ricercatore principale

Patologie

Partner

Coordinatore

  • Ministry of Health and Care Services, Norvegia

Partner

  • Austrian National Public Health Institute, Austria
  • Sciensano, Belgio
  • National Center of Public Health and analysis, Bulgaria
  • Croatian Institute of Public Health
  • National Institute of Public Health, Repubblica Cieca
  • Region of Southern Denmark, Vejle
  • The national Institute for Health Development, Estonia
  • Finnish institute for Health and Welfare, Finlandia
  • French Ministry of Health and Prevention Francia
  • Federal Centre for Health Education, Germania
  • Greek Ministry of Health, Grecia
  • National Public Health Center of Hungary, Ungheria
  • The Directorate of Health for Iceland, Islanda
  • HSE's National cancer Control Programme of Ireland, Irlanda
  • Istituto Superiore di Sanità, Italia
  • The Ministry of Health of the Republic of Lithuania, Lituania
  • Ministry of Health, St Luke's Hospital of Malta, Malta
  • Medical University of Silesia, Polonia
  • Portuguese Directorate General of Health, Portogallo
  • Romanian National institute of public health, Romania
  • Slovenian National institute for Public Health, Slovenia
  • Public health agency of Sweden, Svezia
  • FISABIO, Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Spagna
  • Public Health Center of Ministry of health in Ukraine, Ucraina

Enti affiliati

  • Folkehelseinstituttet, Ministry of Health and Care Services, Norvegia
  • The municipality of Kristiansand, Novergia
  • Agder Fylkeskommune, Norvegia
  • Oslo University Hospital, Norvegia
  • Austrian Agency for Health and Food Safety, Vienna
  • Walloon Agency for Health, Social Protection, Disability and Families, known as the Agency for the Quality of Life (AVIQ), Belgio
  • Ghent University, Belgio
  • Belgian Cancer Registry, Belgio
  • The University of Leuven, Belgio
  • Federal Public Service (FPS), Health, Food Chain Safety and Environment, Belgio
  • Institut Jules Bordet, Belgio
  • Masaryk Memorial Cancer Institute, Repubblica Cieca
  • The municipality of Vejle, Danimarca
  • The municipality of Kolding, Danimarca
  • The municipality of Københavns, Danimarca
  • The Danish Veterinary and Food Administration, Danimarca
  • University of Tartu, Estonia
  • Cancer society of Finland, Finlandia
  • Finnish Lung Health Association, Finlandia
  • Natural resource Institute Finland, Finlandia
  • UKK Institute, Finlandia
  • Centre Hospitalier Universitaire de Montpellier, Francia
  • Agence Nationale de Sécurité Sanitaire de l'Alimentation, de l'Environnement et du Travail, Francia
  • Centre Hospitalier Universitaire de Toulouse, Francia
  • French National Cancer Institute, Francia
  • French Network of Healthy Cities, Francia
  • Santè Publique France, Francia
  • Institut National De La Santé Et De La Recherche Médicale, Francia
  • Institut national de recherche pour l’agriculture l’alimentation et l’environnement (INRAE), Francia
  • UNICANCER, Francia
  • Ecole des Hautes Etudes en Santé Publique, Francia
  • CHU de la Martinique, Francia
  • Ministère de l'Agriculture et de la Souveraineté alimentaire, Francia
  • Health Data Hub, Francia
  • Robert Koch Institute, Germania
  • Max Rubner-Institut Federal Research Institute of Nutrition and Food, Germania
  • Leibniz Institute for Prevention Research and Epidemiology - BIPS, Germania
  • Hannover Medical School, Germania
  • IDIKA SA, the Department of Electronic prescription & department general secretariat of Social Security, Grecia
  • Institouton Ygeias Tou Paidiou, Grecia
  • Dental Society Of Piraeus, Grecia
  • Charokopeio Panepistimio, Grecia
  • University of West Attica, Grecia
  • National and Kapodistrian University of Athens, Grecia
  • National Institute Of Pharmacy And Nutrition, Ungheria
  • Development Centre for Primary Healthcare in Iceland, Islanda
  • National University Hospital of Iceland, Islanda
  • The Prime Minister’s Office, the department of Policy and Coordination, Islanda
  • University College Cork, Irlanda
  • Food Safety Authority of Ireland, Irlanda
  • Ministero della Salute, Italia
  • Catholic University, Italia
  • Institute for Cancer Study, Prevention and Network, Italia
  • Marche Region, Italia
  • Calabria Region, Italia
  • Rome University "La Sapienza", Italia
  • Centro di Riferimento Oncologico di Aviano, Italia
  • Azienda Zero, Italia
  • University of Turin, Italia
  • University Hospital Unit Turin City of Health and Science, Italia
  • Local Health Unit Rome2, Italia
  • National Cancer Institute - Milan, Italia
  • National Institute for Elderly Care, Italia
  • Vilnius university hospital Santaros klinikos, Lituania
  • Hospital of Lithuanian University of Health Sciences Kauno klinikos, Lituania
  • City of Rybnik, Polonia
  • City of Zabrze, Polonia
  • Institute of Public Health of University of Porto, Portogallo
  • University of Lubljana, Slovenia
  • Regional Cancer Center Stockholm Gotland, Svezia
  • Fundacion Instituto de Investigación Marqués de Valdecilla, Spagna
  • Catalan Institute of Oncology, Spagna
  • Agencia Española de Seguridad Alimentaria y Nutrición, Spagna

Finanziamento assegnato all'istituto

50.397 €
JA Prevent NCD
Co-funded by EU